Verge Genomics, On A Quest To Cure Neurodegenerative Disorders, Picks Up $4M Seed
November 03, 2015 at 10:26 AM EST
Verge Genomics, the YC-backed company that looks to use algorithms to help cure neurodegenerative disorders, has announced the close of a $4 million seed round led by IA Ventures, with participation from Two Sigma Ventures, Draper Associates, Great Oaks VC, Slow Ventures, Karlin Venture, Elad Gil and David Lee. Verge Genomics works by creating algorithms that make pharmaceutical creation far… Read More
